CA3106903A1 - Fatty acid derivative labeled with positron-emitting radionuclide - Google Patents
Fatty acid derivative labeled with positron-emitting radionuclide Download PDFInfo
- Publication number
- CA3106903A1 CA3106903A1 CA3106903A CA3106903A CA3106903A1 CA 3106903 A1 CA3106903 A1 CA 3106903A1 CA 3106903 A CA3106903 A CA 3106903A CA 3106903 A CA3106903 A CA 3106903A CA 3106903 A1 CA3106903 A1 CA 3106903A1
- Authority
- CA
- Canada
- Prior art keywords
- fatty acid
- salt
- acid derivative
- compound
- heart disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/54—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and unsaturated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/001—Acyclic or carbocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01T—MEASUREMENT OF NUCLEAR OR X-RADIATION
- G01T1/00—Measuring X-radiation, gamma radiation, corpuscular radiation, or cosmic radiation
- G01T1/16—Measuring radiation intensity
- G01T1/161—Applications in the field of nuclear medicine, e.g. in vivo counting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Physics & Mathematics (AREA)
- High Energy & Nuclear Physics (AREA)
- Molecular Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nuclear Medicine (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018-136483 | 2018-07-20 | ||
| JP2018136483 | 2018-07-20 | ||
| PCT/JP2019/028380 WO2020017620A1 (ja) | 2018-07-20 | 2019-07-19 | 陽電子放出核種で標識された脂肪酸誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3106903A1 true CA3106903A1 (en) | 2020-01-23 |
Family
ID=69164918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3106903A Pending CA3106903A1 (en) | 2018-07-20 | 2019-07-19 | Fatty acid derivative labeled with positron-emitting radionuclide |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12029797B2 (https=) |
| EP (1) | EP3825302B1 (https=) |
| JP (1) | JP7375755B2 (https=) |
| KR (1) | KR102718221B1 (https=) |
| CN (1) | CN112638868B (https=) |
| AU (1) | AU2019304781B2 (https=) |
| CA (1) | CA3106903A1 (https=) |
| ES (1) | ES3009015T3 (https=) |
| WO (1) | WO2020017620A1 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230065079A1 (en) * | 2020-01-17 | 2023-03-02 | Astellas Pharma Inc. | Fatty acid derivative labeled with positron-emitting radionuclide |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES3009015T3 (en) | 2018-07-20 | 2025-03-25 | Astellas Pharma Inc | Fatty acid derivative labeled with positron-emitting radionuclide |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2828623C2 (de) | 1978-06-29 | 1983-11-17 | Kernforschungsanlage Jülich GmbH, 5170 Jülich | Mit radioaktivem Flour markierte C↓1↓↓6↓-bis C↓1↓↓8↓- Fettsäuren, ein Verfahren zu ihrer Herstellung sowie deren Verwendung |
| WO2000063216A1 (en) | 1999-04-19 | 2000-10-26 | Duke University | F-18-labeled thia fatty acids and methods of making and using the same |
| CA2522737C (en) * | 2003-04-17 | 2017-06-06 | The General Hospital Corporation | Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid |
| CN1217924C (zh) | 2003-10-17 | 2005-09-07 | 江苏省原子医学研究所 | 一种氟标记脂肪酸心肌代谢显像剂14(r,s)－氟[18f]－6－硫十七烷酸的纯化方法 |
| CA2760334A1 (en) | 2009-05-04 | 2010-11-11 | Washington University | Pet radiotracers for imaging fatty acid metabolism and storage |
| WO2014179341A1 (en) | 2013-04-29 | 2014-11-06 | Matinas Biopharma, Inc. | Treatment with omega-3 fatty acid compositions |
| WO2015023631A2 (en) | 2013-08-12 | 2015-02-19 | Carolyn Anderson | Fatty acid analogs and their use |
| CN105523977B (zh) | 2016-02-04 | 2017-05-24 | 河南中医学院 | [11c]‑巯甲基脂肪酸的制备方法与应用 |
| ES3009015T3 (en) | 2018-07-20 | 2025-03-25 | Astellas Pharma Inc | Fatty acid derivative labeled with positron-emitting radionuclide |
| US20230065079A1 (en) | 2020-01-17 | 2023-03-02 | Astellas Pharma Inc. | Fatty acid derivative labeled with positron-emitting radionuclide |
-
2019
- 2019-07-19 ES ES19837826T patent/ES3009015T3/es active Active
- 2019-07-19 KR KR1020217001389A patent/KR102718221B1/ko active Active
- 2019-07-19 JP JP2020531374A patent/JP7375755B2/ja active Active
- 2019-07-19 US US17/261,328 patent/US12029797B2/en active Active
- 2019-07-19 EP EP19837826.7A patent/EP3825302B1/en active Active
- 2019-07-19 CN CN201980048149.8A patent/CN112638868B/zh active Active
- 2019-07-19 CA CA3106903A patent/CA3106903A1/en active Pending
- 2019-07-19 AU AU2019304781A patent/AU2019304781B2/en active Active
- 2019-07-19 WO PCT/JP2019/028380 patent/WO2020017620A1/ja not_active Ceased
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230065079A1 (en) * | 2020-01-17 | 2023-03-02 | Astellas Pharma Inc. | Fatty acid derivative labeled with positron-emitting radionuclide |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019304781B2 (en) | 2023-12-21 |
| US20210338845A1 (en) | 2021-11-04 |
| CN112638868B (zh) | 2023-06-20 |
| KR102718221B1 (ko) | 2024-10-15 |
| US12029797B2 (en) | 2024-07-09 |
| ES3009015T3 (en) | 2025-03-25 |
| EP3825302A1 (en) | 2021-05-26 |
| CN112638868A (zh) | 2021-04-09 |
| WO2020017620A1 (ja) | 2020-01-23 |
| EP3825302B1 (en) | 2025-01-08 |
| AU2019304781A1 (en) | 2021-02-11 |
| KR20210032392A (ko) | 2021-03-24 |
| JP7375755B2 (ja) | 2023-11-08 |
| EP3825302A4 (en) | 2022-05-04 |
| JPWO2020017620A1 (ja) | 2021-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7209897B2 (ja) | Ｃｒｂｎタンパク質モジュレーターとしての二環式化合物 | |
| CN112955453A (zh) | 作为选择性Trk抑制剂的吡唑并嘧啶衍生物 | |
| CN112175025B (zh) | 一种含苯环的葡萄糖衍生物及其应用 | |
| AU2019304781B2 (en) | Fatty acid derivative labeled with positron-emitting radionuclide | |
| CN102741264A (zh) | 前列腺特异性膜抗原抑制剂 | |
| JP7777542B2 (ja) | イノシトール誘導体及びその使用 | |
| JP6048958B2 (ja) | 副腎疾患の画像診断剤 | |
| EP4095126A1 (en) | Fatty acid derivative labeled by positron-emitting nuclide | |
| FR3068695B1 (fr) | Composes utiles comme agent d'imagerie de l'hypoxie | |
| EP2744776A1 (en) | New ligands for targeting of s1p receptors for in vivo imaging and treatment of diseases | |
| JP2015110563A (ja) | アルドステロン合成酵素阻害剤 | |
| WO2000063216A1 (en) | F-18-labeled thia fatty acids and methods of making and using the same | |
| JP2024516393A (ja) | ハンチンチンタンパク質をイメージングするための重水素化化合物及びイメージング剤 | |
| WO2026029180A1 (ja) | 放射性トリフェニルピラゾール化合物 | |
| WO2025142589A1 (ja) | 化合物またはその塩もしくは溶媒和物、それらの利用およびそれらの製造方法 | |
| JP2015093833A (ja) | 放射性ハロゲン標識化合物又はその塩、これを含む医薬 | |
| JP2019085344A (ja) | 放射性フッ素標識化合物 | |
| CN119365476A (zh) | 一种环戊基腺苷衍生物及其药物用途 | |
| CN115141087A (zh) | Pet前体关键中间体的异构体的合成方法及其用途 | |
| HK40083691A (en) | Inositol derivative and use thereof | |
| HK1239681A1 (en) | Radioactive halogen-labeled pyrido[1,2-a]benzimidazole derivative compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20240116 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20250206 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD Year of fee payment: 6 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250527 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20250530 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250605 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250605 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250611 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250725 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250725 |